Are you switching from COPAXONE® (glatiramer acetate injection)?
You and your doctor, pharmacist, or healthcare plan may have decided that it’s time to switch to Glatopa. Not to worry! You can expect a quality medicine and support services similar to what you are already accustomed to.
A generic backed by GlatopaCare support services that help with a seamless transition
The active ingredient in Glatopa, glatiramer acetate, is the same one you've been receiving with COPAXONE®.
- Keep your routine. Since Glatopa contains the same active ingredient, same dosage strength options, and is administered the same way, you can keep your same dosing schedule1
- Similar injection device, free of charge. The Glatopaject® injection device is similar to other devices on the market, so your injection experience will feel familiar. You will receive a free Glatopaject device when you enroll in GlatopaCare
- Similar support. GlatopaCare offers support services you've come to expect like $0 Co-Pay for eligible* patients, financial assistance, and injection support2
- Nearly 30,000 people have been prescribed once-daily Glatopa 20 mg/mL, which has been available since 20152
- Brought to you by Sandoz, a Novartis Division and one of the top generic pharmaceutical companies in the world
Dosing options to fit you
3-times-a-week 40 mg/mL3
Once-daily 20 mg/mL3
Injection training videos
You can watch our video tutorials at any time to learn more about your device. Common questions are answered in our FAQs, and you can view the Glatopaject Demonstration Video at any time for a refresher on the injection technique.
Glatopaject Instructions for Use
Download this PDF at any time for step-by-step instructions on using Glatopaject.
Enroll in GlatopaCare and start your treatment with confidence
Once your doctor prescribes you Glatopa, we can help you start and feel comfortable with your medicine in 3 easy steps. GlatopaCare support services are also available to family and caregivers.
Enroll in GlatopaCare and the $0 Co-Pay Program
Enrolling in GlatopaCare is a simple way to ensure you get the help you need to start and stay on Glatopa.
Just call 1.855.GLATOPA or click the button below to enroll online. Once enrolled, you can apply for the $0 Co-Pay Program.*
Meet your GlatopaCare Specialist
Your GlatopaCare Specialist can help you with any questions regarding insurance and Co-Pay eligibility.* They can also connect you with a Nurse Trainer to assist with injection training.
Dedicated specialists are available 8am-8pm ET M-F. If after hours, leave a message.
Get individualized injection training
Just call 1.855.GLATOPA to set up an appointment.
Your GlatopaCare Nurse Trainer can meet with you at your home or call you on the phone. He or she will provide instruction on administering Glatopa and using the Glatopaject injection device.
Nurse Trainers are also available by phone 24/7. Call a Nurse Trainer with your questions related to Glatopa, at any time of day or night.
Have questions about GlatopaCare?
Call 1.855.GLATOPA (1.855.452.8672) or request a call from a GlatopaCare Specialist
*Glatopa Co-Pay Program Eligibility
The Glatopa Co-Pay Program provides up to $9,000 in annual Co-Pay support for Glatopa prescriptions. This program is not health insurance. This program is for insured patients only; uninsured cash-paying patients are not eligible. Patients are not eligible if prescriptions are paid, in whole or in part, by any state or federally funded programs, including but not limited to Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DOD, or TriCare, or private indemnity, or HMO insurance plans that reimburse you for the entire cost of your prescription drugs, or where prohibited by law. Card may not be combined with any other rebate, coupon, or offer. Card has no cash value. Sandoz reserves the right to rescind, revoke, or amend this offer without further notice.
Glatopa® (glatiramer acetate injection) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Important Safety Information
Do not take Glatopa® if you are allergic to glatiramer acetate, mannitol, or any of the ingredients in Glatopa.
Some patients report a short-term reaction right after or within minutes after injecting glatiramer acetate. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain, fast heartbeat, anxiety, and trouble breathing. These symptoms generally appear within seconds to minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again.
Chest pain may occur either as part of the immediate post-injection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense.
A permanent indentation under the skin (lipoatrophy) or, rarely, necrosis at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.
Liver problems, including liver failure, can occur with Glatopa. Call your healthcare provider right away if you have symptoms, such as: nausea, loss of appetite, tiredness, dark colored urine and pale stools, yellowing of your skin or the white part of your eye, bleeding more easily than normal, confusion, sleepiness.
The most common side effects in studies of glatiramer acetate injection are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of glatiramer acetate. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking Glatopa.
To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see full Prescribing Information for Glatopa.
1. U.S. Department of Health & Human Services. Approved Drug Products With Therapeutic Equivalence Evaluations: 41st Edition. Washington, DC: US Department of Health and Human Services; 2021. 2. Data on file [IMS SMART data]. Princeton, NJ: Sandoz Inc; 2020. 3. Glatopa Prescribing Information. Sandoz Inc. April 2022.